Invest in GoHealth Inc. (GOCO) to keep your portfolio healthy

After finishing at $8.85 in the prior trading day, GoHealth Inc. (NASDAQ: GOCO) closed at $9.03, up 2.03%. In other words, the price has increased by $+0.18 from its previous closing price. On the day, 130934 shares were traded. GOCO stock price reached its highest trading level at $9.39 during the session, while it also had its lowest trading level at $8.77.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



Our goal is to gain a better understanding of GOCO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 2.05 whereas as Long-Term Debt/Eq ratio is at 2.03.

Upgrades & Downgrades

On March 03, 2022, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform and also lowered its target price recommendation from $10 to $2.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 when CCP III Cayman GP Ltd. bought 61,334 shares for $7.92 per share. The transaction valued at 485,555 led to the insider holds 3,428,554 shares of the business.

CB Blizzard Holdings C, L.P. bought 61,334 shares of GOCO for $485,555 on Nov 21. The 10% Owner now owns 3,428,554 shares after completing the transaction at $7.92 per share. On Nov 18, another insider, CB Blizzard Holdings C, L.P., who serves as the 10% Owner of the company, bought 49,447 shares for $7.75 each. As a result, the insider paid 383,028 and bolstered with 3,367,220 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24 while its Price-to-Book (P/B) ratio in mrq is 3.69.

Stock Price History:

Over the past 52 weeks, GOCO has reached a high of $63.60, while it has fallen to a 52-week low of $4.93. The 50-Day Moving Average of the stock is 6.09, while the 200-Day Moving Average is calculated to be 11.52.

Shares Statistics:

The stock has traded on average 72.80K shares per day over the past 3-months and 231.85k shares per day over the last 10 days, according to various share statistics. A total of 132.38M shares are outstanding, with a floating share count of 81.71M. Insiders hold about 12.20% of the company’s shares, while institutions hold 40.50% stake in the company. Shares short for GOCO as of Oct 13, 2022 were 3.83M with a Short Ratio of 0.33M, compared to 3.97M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.89% and a Short% of Float of 4.60%.

Earnings Estimates

Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.25 for the current quarter, with a high estimate of -$0.11 and a low estimate of -$0.5, while EPS last year was -$0.18. The consensus estimate for the next quarter is $0.13, with high estimates of $0.15 and low estimates of $0.11.

Analysts are recommending an EPS of between -$0.3 and -$0.68 for the fiscal current year, implying an average EPS of -$0.52. EPS for the following year is -$0.26, with 5 analysts recommending between $0.23 and -$0.65.

Revenue Estimates

6 analysts predict $135.38M in revenue for the current quarter. It ranges from a high estimate of $180.1M to a low estimate of $100M. As of the current estimate, GoHealth Inc.’s year-ago sales were $211.73M, an estimated decrease of -36.10% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $403.15M, a decrease of -10.30% over than the figure of -$36.10% in the same quarter last year. There is a high estimate of $480.81M for the next quarter, whereas the lowest estimate is $354.86M.

A total of 6 analysts have provided revenue estimates for GOCO’s current fiscal year. The highest revenue estimate was $1.09B, while the lowest revenue estimate was $885.3M, resulting in an average revenue estimate of $967.81M. In the same quarter a year ago, actual revenue was $1.06B, down -8.90% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $1.01B in the next fiscal year. The high estimate is $1.17B and the low estimate is $835M. The average revenue growth estimate for next year is up 4.30% from the average revenue estimate for this year.